The efficacy of cognitive behavioral therapy for emotional disorders.

Author(s):  
Lorenzo Lorenzo-Luaces ◽  
Lotte H. J. M. Lemmens ◽  
John R. Keefe ◽  
Pim Cuijpers ◽  
Claudi L. H. Bockting
2020 ◽  
pp. 46-52
Author(s):  
V. A. Parfenov ◽  
E. V. Parfenova

Low back pain or lumbalgia is one of the most common reasons for going to the doctor. Non-specific (musculoskeletal) pain is the most common (90%) cause of chronic lumbalgia. The chronic course of lumbalgia is determined not only by the anatomical sources of pain, but also by psychological and social factors that should be considered when managing patients. In the treatment of chronic nonspecific lumbalgia, a comprehensive multidisciplinary approach is effective, including optimization of drug therapy and motor activity, psychological methods (cognitive-behavioral therapy), an educational program, and manual therapy. When identifying common emotional disorders and insomnia, their therapy is required. Kinesitherapy (therapeutic gymnastics) is the most effective direction in the treatment of chronic nonspecific lumbalgia; оf primary importance are the regularity of physical exercises under the supervision of a specialist, the exclusion of sudden and excessive movements. In combination with activities, regular walking is highly effective. Cognitive-behavioral therapy is the most effective psychological direction in the management of patients with chronic nonspecific lumbalgia. It should be aimed not only at pain, but also at those often found in chronic non-specific lumbalgia insomnia, depression, and anxiety disorders. In some patients with damage to the facet joints, the sacroiliac joint, radiofrequency denervation or therapeutic blockades with anesthetics and corticosteroids can be used. Nonsteroidal anti-inflammatory drugs are used as medicines for chronic nonspecific lumbalgia, when prescribing them, it is necessary to take into account the presence and nature of risk factors for adverse events, concomitant diseases, interaction with other drugs The use of etoricoxib in chronic non-specific lumbalgia is discussed.


2018 ◽  
Vol 17 (6) ◽  
pp. 387-405 ◽  
Author(s):  
Kelly R. Harris ◽  
Peter J. Norton

A recent shift in the conceptualization of both depressive and anxiety disorders supports the notion that these disorders may best fall under a single classification of “emotional disorders.” This understanding has resulted in the development of various transdiagnostic cognitive behavioral therapy (tCBT) protocols to address underlying core pathology shared by emotional disorders. While there is evidence to suggest tCBT is effective in reducing co-occurring depression, research into the efficacy of face-to-face tCBT has generally focused on the delivery of tCBT to individuals with predominantly anxiety diagnoses. The current case study aims to expand the research by examining the impact of group tCBT for individuals with a principal depressive diagnosis. A session-by-session explanation of a 12-week group tCBT protocol designed to treat a heterogeneous group of individuals diagnosed with an emotional disorder is provided in detail and accompanied by a quantitative case study of a recently delivered treatment group. The case study demonstrates the feasibility and pragmatic application of the group tCBT treatment approach. Data presented support the continued research of transdiagnostic interventions for the treatment of emotional disorders and justify future randomized controlled trials to further evaluate the presented intervention.


2009 ◽  
Vol 23 (1) ◽  
pp. 60-66 ◽  
Author(s):  
David A. Clark ◽  
Steven Taylor

Transdiagnostic cognitive-behavioral therapy (CBT) for anxiety and depression has been of growing interest in psychotherapy research. In this article we discuss several fundamental issues raised by contributors to this special issue on transdiagnostic CBT for emotional disorders. Although researchers have tended to assume that interventions are transdiagnostic because they are labeled as such, the actual boundary between transdiagnostic and disorderspecific treatments may be far less clear than previously acknowledged. Nevertheless, there are many reasons to advocate for greater attention to a transdiagnostic perspective, not the least being the large shared variance in the emotional disorders, which is often overlooked in contemporary disorder-specific CBT protocols. Evidence of the efficacy of transdiagnostic CBT for anxiety and depression is limited, and issues facing comparative outcome and process studies are discussed. The article concludes by suggesting a programmatic framework for advancing a theory-driven, empirically based psychotherapy research agenda that could lead to the development of a truly integrated, transdiagnostic CBT for anxiety and depression.


Sign in / Sign up

Export Citation Format

Share Document